Tag Archives: anaphylaxis

Supply Disruption Alert – EpiPen adrenaline auto-injectors

The Department of Health & Social Care (DHSC) have issued the attached Supply Disruption Alert (SDA) with advice on managing issues due to shortage of EpiPen adrenaline auto-injectors.

DownloadThe SDA recommends that all health care professionals ensure that:

  1. Adult and child adrenaline auto-injectors are only prescribed and dispensed to those who truly need them.
  2. Repeat prescriptions and supply are managed diligently and patients advised that:
    • they should NOT dispose of their expired devices until they have replaced them.
    • adrenaline auto-injectors expire on the last day of the month indicated – a device labelled ‘April 2019’ does not expire until the end of April 2019.
    • The MHRA have extended the use by date of certain batches of adult EpiPen by four months (see below or here).
LOT Labelled Expiry Date (end of the month) Extended Use by Date (end of the month)
6FA794J 07.2018 11.2018
6FA795Y 07.2018 11.2018
7FA112F 09.2018 01.2019
7FA106B 09.2018 01.2019
7FA283B 10.2018 02.2019
7FA251D 10.2018 02.2019
7FA250B 10.2018 02.2019
7FA265C 11.2018 03.2019
7FA265B 11.2018 03.2019
  1. Where possible, prescribers should not prescribe a replacement adult EpiPen whilst the original is within the extended use by date.
  2. Some adults and children may need to switch from their usual device to alternative adrenaline auto-injector devices. The different brands of adrenaline auto-injectors are not used in exactly the same way and specific training and advice is required. See attached guidance.
  3. Junior adrenaline auto-injectors (150mcg) must only be dispensed to children under 30kg, in line with the existing established guidance. Other children weighing more than 30kg need to be given adult auto-injectors (300mcg). See attached guidance & BSACI guideline.
  4. Prescribers should work in close collaboration with local pharmacies to understand which devices are available. Prescribers and pharmacists should work together to ensure patients who are switched to an alternative device are trained appropriately and understand how to use the new device.
  5. Prescribers and pharmacies should regularly check the Specialist Pharmacy Services website for updates: https://www.sps.nhs.uk/articles/shortage-of-epipen/

Adrenaline auto-injectors: updated advice after European review

The MHRA have issued updated advice on adrenaline auto-injectors to recommend that 2 adrenaline auto-injectors are prescribed, which patients should carry at all times.

Advice for healthcare professionals:

  • it is recommended that 2 adrenaline auto-injectors are prescribed, which patients should carry at all times
  • ensure that people with allergies and their carers have been trained to use the particular auto-injector that they have been prescribed—technique varies between injectors
  • encourage people with allergies and their carers to obtain and practise using a trainer device (available for free from the manufacturers’ websites)

Advice to give to people with allergies and their carers:

  • it is recommended that you carry 2 adrenaline auto-injectors at all times; this is particularly important for people who also have allergic asthma because they are at increased risk of a severe anaphylactic reaction
  • use the adrenaline auto-injector at the first signs of a severe allergic reaction
  • take the following actions immediately after every use of an adrenaline auto-injector:
    1. call 999, ask for an ambulance and state “anaphylaxis”, even if symptoms are improving
    2. lie flat with legs raised to maintain blood flow. However, if you have breathing difficulties, you may need to sit up to make breathing easier
    3. seek help immediately after using the auto-injector and if at all possible make sure someone stays with you while waiting for the ambulance
    4. if you do not start to feel better, use the second auto-injector 5–15 minutes after the first one
  • check the expiry date of the adrenaline auto-injectors and obtain replacements before they expire; expired injectors will be less effective

For more information, please see the MHRA Drug Safety Update website.

Drug Safety Update volume 11 issue 1, August 2017: 3.